Actively Recruiting
NAFLD Clinical Care Pathway
Led by VA Office of Research and Development · Updated on 2025-11-14
32
Participants Needed
1
Research Sites
249 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD. Therefore, the burden of NAFLD and its complications among Veterans is substantial. However, most VA patients with NAFLD are undiagnosed and untreated, and their care is not consistent with practice guidelines. The NAFLD Clinical Care Pathway (NCCP) intervention seeks to close this major gap in the care of Veterans by automatically identifying patients at risk of NAFLD, calculating their risk scores of having severe NAFLD, and educating the primary care providers on the diagnosis and treatment of NAFLD. This clinical trial will test the benefit of this NCCP intervention against usual care in increasing the rates of NAFLD diagnosis as well as referral to and enrollment in appropriate treatment. The study will also identify barriers and promotors of future NCCP implementation.
CONDITIONS
Official Title
NAFLD Clinical Care Pathway
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient Aligned Care Teams (PACT) at the Michael E. DeBakey VA Medical Center
You will not qualify if you...
- PACTs with unstable leadership (pending departure or vacancy) at time of randomization
- PACTs that participated in focus groups during the first study aim to avoid cross contamination
- PACTs that do not treat NAFLD
- PACTs not located at the main hospital
- PACTs with fewer than 100 visits within 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States, 77030-4211
Actively Recruiting
Research Team
H
Hashem B El-Serag, MD MPH
CONTACT
K
Kyler Godwin, PhD MPH BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here